Professor Farah is a dual trained and practicing oral medicine specialist and oral & maxillofacial pathologist with a research focus on optical imaging and molecular genomics of head and neck cancers. In addition to his clinical and research appointments, Camile is CEO & Managing Director of Optiscan Imaging, an Australian publicly listed medical technology company which develops, manufactures, and commercialises digital pathology and precision surgery hardware and software solutions enabling live optical biopsy for diagnostic and surgical applications. Camile is Vice President of the ANZ Head and Neck Cancer Society and Convenor of its 2027 ASM to be held in Perth, Western Australia.